Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Sesen Bio: Q3 Earnings Insights

Sesen Bio (NASDAQ:SESN) reported its Q3 earnings results on Monday, November 7, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Sesen Bio beat estimated earnings by 166.67%, reporting an EPS of $0.1 versus an estimate of $-0.15.
byBenzinga Insights
November 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Sesen Bio (NASDAQ:SESN) reported its Q3 earnings results on Monday, November 7, 2022 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Sesen Bio beat estimated earnings by 166.67%, reporting an EPS of $0.1 versus an estimate of $-0.15.

Revenue was up $40.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.09 which was followed by a 3.33% drop in the share price the next day.

 

To track all earnings releases for Sesen Bio visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: Exxon Mobil Q3 Earnings

By Benzinga Insights
October 28, 6:52 AM
Exxon Mobil (NYSE:XOM) reported its Q3 earnings results on Friday, October 28, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Exxon Mobil beat estimated earnings by 21.92%, reporting an EPS of $4.45 versus an estimate of $3.65.

XOM

Read More

Earnings Outlook For MariMed

By Benzinga Insights
November 4, 1:15 PM
MariMed (OTC:MRMD) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that MariMed will report an earnings per share (EPS) of $0.01.

MRMD